These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17138688)

  • 1. Cost-optimisation of screening for latent tuberculosis in close contacts.
    Sadatsafavi M; Najafzadeh M
    Eur Respir J; 2006 Dec; 28(6):1285; author reply 1285-6. PubMed ID: 17138688
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-optimisation of screening for latent tuberculosis in close contacts.
    Diel R; Nienhaus A; Lange C; Schaberg T
    Eur Respir J; 2006 Jul; 28(1):35-44. PubMed ID: 16571615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct costs of three models for the screening of latent tuberculosis infection.
    Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2006 Jul; 28(1):45-50. PubMed ID: 16611659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
    Diel R; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk/cost analysis of alternative screening intervals for occupational tuberculosis infection.
    Nicas M
    Am Ind Hyg Assoc J; 1998 Feb; 59(2):104-12. PubMed ID: 9487664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
    Oxlade O; Schwartzman K; Menzies D
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
    Verma G; Chuck AW; Jacobs P
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis.
    Jones TF; Schaffner W
    Am J Respir Crit Care Med; 2001 Jul; 164(1):77-81. PubMed ID: 11435242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts.
    Richeldi L; Bergamini BM; Vaienti F
    Eur Respir J; 2008 Aug; 32(2):524-5. PubMed ID: 18669795
    [No Abstract]   [Full Text] [Related]  

  • 11. An alternative to 'two-step' tuberculin skin testing for Southeast Asian refugees.
    Wenzel M
    Nurse Pract; 1991 Sep; 16(9):25-8. PubMed ID: 1945074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of latent tuberculosis infection in immigrants.
    Menzies D; Schwartzman K
    N Engl J Med; 2003 Mar; 348(13):1289-92; author reply 1289-92. PubMed ID: 12661572
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of interferon-gamma-based blood tests for the detection of latent tuberculosis infection.
    Davies PD; Drobniewski F
    Eur Respir J; 2006 Jul; 28(1):1-3. PubMed ID: 16816343
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
    Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of tuberculosis screening in health care workers is not robust.
    Mancuso J; Niebuhr D; Krauss MR; Dabbs C; Anderson K
    Arch Intern Med; 2009 Jul; 169(14):1336; author reply 1336-7. PubMed ID: 19636037
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
    Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diaskintest for children and teenagers screening on the tuberculous infection: accesses to pricing and analysis charges--effectiveness].
    Kulikov AIu; Zinchuk IIu; Protsenko MV; Krysanov IS
    Tuberk Biolezni Legkih; 2009; (9):41-6. PubMed ID: 19882861
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees.
    Dasgupta K; Menzies D
    Eur Respir J; 2005 Jun; 25(6):1107-16. PubMed ID: 15929967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.